Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here is one stock under $10 that could 100x and two that could be down big.
Two Stocks Under $10 to Sell:
3D Systems (DDD)
Share Price: $3.05
Founded by the inventor of stereolithography, 3D Systems (NYSE: DDD) engineers, manufactures, and sells 3D printers and other related products to the aerospace, automotive, healthcare, and consumer goods industries.
Why Do We Pass on DDD?
- Sales tumbled by 6.3% annually over the last five years, showing market trends are working against its favor during this cycle
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
- Short cash runway increases the probability of a capital raise that dilutes existing shareholders
3D Systems is trading at $3.05 per share, or 1.4x forward price-to-sales. To fully understand why you should be careful with DDD, check out our full research report (it’s free for active Edge members).
Myriad Genetics (MYGN)
Share Price: $8.06
Founded in 1991 as one of the pioneers in translating genetic discoveries into clinical applications, Myriad Genetics (NASDAQ: MYGN) develops genetic tests that assess disease risk, guide treatment decisions, and provide insights across oncology, women's health, and mental health.
Why Are We Out on MYGN?
- Sales trends were unexciting over the last five years as its 5.5% annual growth was below the typical healthcare company
- Negative returns on capital show that some of its growth strategies have backfired, and its shrinking returns suggest its past profit sources are losing steam
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
At $8.06 per share, Myriad Genetics trades at 222.6x forward P/E. If you’re considering MYGN for your portfolio, see our FREE research report to learn more.
One Stock Under $10 to Watch:
Target Hospitality (TH)
Share Price: $7.35
Building mini-communities at places such as oil drilling sites, Target Hospitality (NASDAQ: TH) is a provider of specialty workforce lodging accommodations and services.
Why Are We Positive On TH?
- Disciplined cost controls and effective management resulted in a strong two-year operating margin of 25.9%
- TH is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders
- Rising returns on capital show management is finding more attractive investment opportunities
Target Hospitality’s stock price of $7.35 implies a valuation ratio of 22.3x forward EV-to-EBITDA. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free for active Edge members .
High-Quality Stocks for All Market Conditions
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
